Waldman Department of Dermatology

Medicine & Life Sciences

1. Psoriasis 100%
2. Atopic Dermatitis 57%
3. Skin 54%
4. Therapeutics 30%
5. Acne Vulgaris 28%
6. Safety 28%
7. Dermatology 19%
8. Psoriatic Arthritis 18%
9. Placebos 15%
10. tazarotene 14%
11. Melanoma 13%
12. Dermatologists 13%
13. Skin Diseases 12%
14. Ustekinumab 11%
15. calcipotriene 11%
16. secukinumab 10%
17. Neoplasms 10%
18. Biological Products 10%
19. Pseudoxanthoma Elasticum 10%
20. halobetasol 10%
21. Adrenal Cortex Hormones 9%
22. dupilumab 9%
23. brodalumab 9%
24. Radiotherapy 8%
25. Actinic Keratosis 8%
26. Ointments 8%
27. Pediatrics 8%
28. Quality of Life 8%
29. Scalp 8%
30. betamethasone-17,21-dipropionate 8%
31. apremilast 7%
32. Genes 7%
33. Pruritus 7%
34. Alopecia Areata 7%
35. Interleukin-17 7%
36. Gels 7%
37. Biopsy 7%
38. Research Personnel 7%
39. Erythema 7%
40. Physicians 7%
41. Etanercept 6%
42. ixekizumab 6%
43. Eczema 6%
44. Clinical Trials 6%
45. Skin Neoplasms 6%
46. Ultraviolet Rays 6%
47. Rosacea 6%
48. Prostatic Neoplasms 6%
49. Pharmaceutical Preparations 6%
50. T-Lymphocytes 6%
51. Phototherapy 6%
52. Cicatrix 6%
53. Hair 6%
54. Population 6%
55. Randomized Controlled Trials 5%
56. Inflammation 5%
57. Child 5%
58. Biological Therapy 5%
59. Retinoids 5%
60. Genome-Wide Association Study 5%
61. Lasers 5%
62. Mohs Surgery 5%
63. Guidelines 5%
64. Alopecia 5%
65. guselkumab 5%
66. Cytokines 5%
67. Biomarkers 5%
68. Vitiligo 5%
69. Imiquimod 5%
70. Hair Follicle 5%
71. Mutation 5%
72. Interleukin-23 5%
73. Collagen 5%